Become a Partner in Sepsis Care
We are actively selecting U.S. hospital systems to participate in our upcoming clinical validation pilots of Medicasci® CDS for Sepsis Risk Prediction.
Why Partner with Medicasci?
- Zero Disruption: Our standardized deployment protocol ensures a frictionless IT experience. We handle the FHIR integration and terminology mapping.
- Safe “Shadow Mode” Validation: We initially run Medicasci SRP silently in the background against your real-time data to prove our accuracy to your clinical leadership before any alerts are turned “live.”
- First-Mover Advantage: Pilot partners receive significant, long-term subsidies on commercial licensing fees post-FDA clearance.
The Deployment Process:
- Compliance: Execute BAA and complete your institution’s security assessment.
- Technical Validation: Establish FHIR connectivity; map local terminologies onto the Medicasci knowledge graph.
- Clinical Validation: Shadow mode testing to demonstrate localized accuracy and customize alert workflow to your Rapid Response Teams.
Medicasci SRP is an investigational device supported by funding from the NIH NIGMS. It is not yet cleared by the FDA for commercial use.
Thank you for your response. ✨
Someone from the Medicasci Sepsis Risk Prediction team will contact you shortly.
